Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture

Molecular Endocrinology

Volumn 20, Issue 12, 2006, Pages 3279-3292

  Paternot, Sabine ^a   Dumont, Jacques E ^a   Roger, Pierre P ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EPIDERMAL GROWTH FACTOR; THYROTROPIN;

ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CELL; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DOGS; EPIDERMAL GROWTH FACTOR; HUMANS; MITOSIS; PHOSPHORYLATION; RATS; SERUM; THYROID GLAND; THYROTROPIN; TRANSFORMING GROWTH FACTOR BETA;

CANIS FAMILIARIS;

EID: 33751522249     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0515     Document Type: Article

References (94)

1. Dumont JE, Maenhaut C, Christophe D, Vassart G, Roger PP 2005 Thyroid regulatory factors. In: DeGroot LJ, Jameson JL, eds. Endocrinology. Philadelphia: Saunders; 1837-1860
2. Roger PP, Servais P, Dumont JE 1983 Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett 157:323-329
3. Roger P, Taton M, Van Sande J, Dumont JE 1988 Mitogenic effects of thyrotropin and adenosine 3′,5′-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 66:1158-1165
4. Huber GK, Safirstein R, Neufeld D, Davies TF 1991 Thyrotropin receptor autoantibodies induce human thyroid cell growth and c-fos activation. J Clin Endocrinol Metab 72:1142-1147
5. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651
6. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401
7. Williams ED 1994 Thyroid tumorigenesis. Horm Res 42:31-34
8. Mazzaferri EL 1990 Thyroid cancer and Graves' disease. J Clin Endocrinol Metab 70:826-829
9. Pohl V, Roger PP, Christophe D, Pattyn G, Vassart G, Dumont JE 1990 Differentiation expression during proliferative activity induced through different pathways: in situ hybridization study of thyroglobulin gene expression in thyroid epithelial cells. J Cell Biol 111:663-672
10. Roger PP, Dumont JE 1984 Factors controlling proliferation and differentiation of canine thyroid cells cultured in reduced serum conditions: effects of thyrotropin, cyclic AMP and growth factors. Mol Cell Endocrinol 36:79-93
11. Paschke R, Eck T, Herfurth J, Usadel KH 1995 Stimulation of proliferation and inhibition of function of xenotransplanted human thyroid tissue by epidermal growth factor. J Endocrinol Invest 18:359-363
12. Bidey SP, Hill DJ, Eggo MC 1999 Growth factors and goitrogenesis. J Endocrinol 160:321-332
13. Melillo RM, Castellone MD, Guarino V, De F, V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M 2005 The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115:1068-1081
14. Mitsutake N, Miyagishi M, Mitsutake S, Akeno N, Mesa JC, Knauf JA, Zhang L, Taira K, Fagin JA 2005 BRAF mediates RET/PTC-induced MAPK activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis. Endocrinology 147:1014-1019
15. Greco A, Roccato E, Pierotti MA 2004 TRK oncogenes in papillary thyroid carcinoma. Cancer Treat Res 122:207-219
16. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457
17. Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE 2005 Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94-101
18. Trovato M, Villari D, Bartolone L, Spinella S, Simone A, Violi MA, Trimarchi F, Batolo D, Benvenga S 1998 Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules. Thyroid 8:125-131
19. Aasland R, Akslen LA, Varhaug JE, Lillehaug JR 1990 Co-expression of the genes encoding transforming growth factor-α and its receptor in papillary carcinomas of the thyroid. Int J Cancer 46:382-387
20. Medina DL, Santisteban P 2000 Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Eur J Endocrinol 143:161-178
21. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by thyrotropin and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656
22. Rivas M, Santisteban P 2003 TSH-activated signaling pathways in thyroid tumorigenesis. Mol Cell Endocrinol 213:31-45
23. Tsygankova OM, Kupperman E, Wen W, Meinkoth JL 2000 Cyclic AMP activates Ras. Oncogene 19:3609-3615
24. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, Meinkoth JL 1999 Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol 19:5882-5891
25. Iacovelli L, Capobianco L, Salvatore L, Sallese M, D'Ancona GM, De Blasi A 2001 Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60:924-933
26. Pomerance M, Abdullah HB, Kamerji S, Correze C, Blondeau JP 2000 Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, Rac 1 and reactive oxygen species. J Biol Chem 275:40539-40546
27. Kambe F, Miyazaki T, Seo H 1996 Differential induction of fos and jun family genes by thyrotropin in rat thyroid FRTL-5 cells. Thyroid 6:123-128
28. Tell G, Pines A, Arturi F, Cesaratto L, Adamson E, Puppin C, Presta I, Russo D, Filetti S, Damante G 2004 Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells. Endocrinology 145:4660-4666
29. Tramontano D, Chin WW, Moses AC, Ingbar SH 1986 Thyrotropin and dibutyryl cyclic AMP increase levels of c-myc and c-fos mRNAs in cultured rat thyroid cells. J Biol Chem 261:3919-3922
30. Yamamoto K, Hirai A, Ban T, Saito J, Tahara K, Terano T, Tamura Y, Saito Y, Kitagawa M 1996 Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells. Endocrinology 137:2036-2042
31. Medina DL, Toro MJ, Santisteban P 2000 Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin E x cyclin-dependent kinase 2 complexes. J Biol Chem 275:15549-15556
32. Correze C, Blondeau JP, Pomerance M 2005 p38 Mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells. Eur J Endocrinol 153:123-133
33. Sherr CJ, McCormick F 2002 The RB and p53 pathways in cancer. Cancer Cell 2:103-112
34. Nedachi T, Akahori M, Ariga M, Sakamoto H, Suzuki N, Umesaki K, Hakuno F, Takahashi SI 2000 Tyrosine kinase and phosphatidylinositol 3-kinase activation are required for cyclic adenosine 3′,5′-monophosphate-dependent potentiation of deoxyribonucleic acid synthesis induced by insulin-like growth factor-I in FRTL-5 cells. Endocrinology 141:2429-2438
35. Villone G, De Amicis F, Veneziani BM, Salzano S, Di Carlo A, Tramontano D 1997 Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin-dependent growth of thyroid cells. Cell Growth Differ 8:1181-1188
36. Burikhanov R, Coulonval K, Pirson I, Lamy F, Dumont JE, Roger PP 1996 Thyrotropin via cyclic AMP induces insulin receptor expression and insulin co-stimulation of growth and amplifies insulin and insulin-like growth factor signaling pathways in dog thyroid epithelial cells. J Biol Chem 271:29400-29406
37. Van Keymeulen A, Roger PP, Dumont JE, Dremier S 2000 TSH and cAMP do not signal mitogenesis through Ras activation. Biochem Biophys Res Commun 273:154-158
38. Coulonval K, Vandeput F, Stein R, Kozma S, Lamy F, Dumont JE 2000 Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochem J 348:351-358
39. Vandeput F, Perpete S, Coulonval K, Lamy F, Dumont JE 2003 Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5′-monophosphate and growth factors. Endocrinology 144:1341-1349
40. Pirson I, Coulonval K, Lamy F, Dumont JE 1996 c-Myc expression is controlled by the mitogenic cAMP-cascade in thyrocytes. J Cell Physiol 168:59-70
41. Reuse S, Pirson I, Dumont JE 1991 Differential regulation of protooncogenes c-jun and jun D expressions by protein tyrosine kinase, protein kinase C, and cyclic-AMP mitogenic pathways in dog primary thyrocytes: TSH and cyclic-AMP induce proliferation but downregulate C-jun expression. Exp Cell Res 196:210-215
42. Deleu S, Pirson I, Clermont F, Nakamura T, Dumont JE, Maenhaut C 1999 Immediate early gene expression in dog thyrocytes in response to growth, proliferation and differentiation stimuli. J Cell Physiol 181:342-354
43. Depoortere F, Van Keymeulen A, Lukas J, Costagliola S, Bartkova J, Dumont JE, Bartek J, Roger PP, Dremier S 1998 A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J Cell Biol 140:1427-1439
44. Depoortere F, Dumont JE, Roger PP 1996 Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells. J Cell Sci 109:1759-1764
45. Lukas J, Bartkova J, Bartek J 1996 Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol 16:6917-6925
46. Van Keymeulen A, Bartek J, Dumont JE, Roger PP 1999 Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture. Oncogene 18:7351-7359
47. Roger PP, Servais P, Dumont JE 1987 Regulation of dog thyroid epithelial cell cycle by forskolin, an adenylate cyclase activator. Exp Cell Res 172:282-292
48. Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP 2000 Transforming growth factor β(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol Biol Cell 11:1061-1076
49. Coulonval K, Bockstaele L, Paternot S, Dumont JE, Roger PP 2003 The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFβ, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Exp Cell Res 291:135-149
50. Paternot S, Coulonval K, Dumont JE, Roger PP 2003 Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. J Biol Chem 278:26533-26540
51. Paternot S, Arsenijevic T, Coulonval K, Bockstaele L, Dumont JE, Roger PP 2006 Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells. Cell Cycle 5:61-70
52. Diehl JA 2002 Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226-231
53. Lamy F, Taton M, Dumont JE, Roger PP 1990 Control of protein synthesis by thyrotropin and epidermal growth factor in human thyrocytes: role of morphological changes. Mol Cell Endocrinol 73:195-209
54. Maenhaut C, Brabant G, Vassart G, Dumont JE 1992 In vitro and in vivo regulation of thyrotropin receptor mRNA levels in dog and human thyroid cells. J Biol Chem 267:3000-3007
55. Ambesi-Impiombato FS, Villone G 1987 The FRTL-5 thyroid cell strain as a model for studies on thyroid cell growth. Acta Endocrinol Suppl (Copenh) 281:242-245
56. Zarkowska T, Mittnacht S 1997 Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272:12738-12746
57. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY 1994 D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076
58. Morris JC3, Ranganathan G, Hay ID, Nelson RE, Jiang NS 1988 The effects of transforming growth factor-β on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology 123:1385-1394
59. Taton M, Lamy F, Roger PP, Dumont JE 1993 General inhibition by transforming growth factor β 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol Cell Endocrinol 95:13-21
60. Sherr CJ, Roberts JM 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
61. Hall M, Bates S, Peters G 1995 Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581-1588
62. Bockstaele L, Kooken H, Libert F, Paternot S, Dumont JE, de Launoit Y, Roger PP, Coulonval K 2006 Regulated activating Thr 172-phosphorylation of CDK4: its relationship with cyclins and CDK "inhibitors." Mol Cell Biol 26:5070-5085
63. Roger PP, Baptist M, Dumont JE 1992 A mechanism generating heterogeneity in thyroid epithelial cells: suppression of the thyrotropin/cAMP-dependent mitogenic pathway after cell division induced by cAMP-independent factors. J Cell Biol 117:383-393
64. van Staveren WCG, Weiss Solis D, Delys L, Venet D, Cappello M, Andry G, Dumont JE, Libert F, Detours V, Maenhaut C 2006 Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis. Proc Natl Acad Sci USA 103:413-418
65. Roger PP, Reuse S, Maenhaut C, Dumont JE 1995 Multiple facets of the modulation of growth by cAMP. Vitam Horm 51:59-191
66. Richards JS 2001 New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 15:209-218
67. Stork PJ, Schmitt JM 2002 Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266
68. Dumaz N, Marais R 2005 Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS J 272:3491-3504
69. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E 1997 New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862
70. Alt JR, Gladden AB, Diehl JA 2002 p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem 277:8517-8523
71. Jones CJ, Kipling D, Morris M, Hepburn P, Skinner J, Bounacer A, Wyllie FS, Ivan M, Bartek J, Wynford-Thomas D, Bond JA 2000 Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol Cell Biol 20:5690-5699
72. Heinrich R, Kraiem Z 1997 The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles. J Clin Endocrinol Metab 82:1839-1844
73. Matsuoka M, Kato JY, Fisher RP, Morgan DO, Sherr CJ 1994 Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol Cell Biol 14:7265-7275
74. Harper JW, Elledge SJ 1998 The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev 12:285-289
75. Motti ML, Boccia A, Belletti B, Bruni P, Troncone G, Cito L, Monaco M, Chiappetta G, Baldassarre G, Palombini L, Fusco A, Viglietto G 2003 Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland. Oncogene 22:7576-7586
76. Bartkova J, Lukas J, Strauss M, Bartek J 1998 Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027-1037
77. Hampl A, Pachernik J, Dvorak P 2000 Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice. Biol Reprod 62:1393-1401
78. Petermann A, Hiromura K, Pippin J, Blonski M, Couser WG, Kopp J, Mundel P, Shankland SJ 2004 Differential expression of d-type cyclins in podocytes in vitro and in vivo. Am J Pathol 164:1417-1424
79. Kiess M, Gill RM, Hamel PA 1995 Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10:159-166
80. Phelps DE, Xiong Y 1998 Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Cell Growth Differ 9:595-610
81. Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, von Boehmer H, Sicinski P 2003 Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4:451-461
82. Adams PD 2001 Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 1471:M123-M133
83. Classon M, Harlow E 2002 The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2:910-917
84. Miccadei S, Provenzano C, Mojzisek M, Giorgio NP, Civitareale D 2005 Retinoblastoma protein acts as Pax 8 transcriptional coactivator. Oncogene 24:6993-7001
85. Eggo MC, King WJ, Black EG, Sheppard MC 1996 Functional human thyroid cells and their insulin-like growth factor-binding proteins: regulation by thyrotropin, cyclic 3′,5′ adenosine monophosphate, and growth factors. J Clin Endocrinol Metab 81:3056-3062
86. Di Matola T, Mueller F, Fenzi G, Rossi G, Bifulco M, Marzano LA, Vitale M 2000 Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. J Clin Endocrinol Metab 85:1188-1193
87. Illario M, Cavallo AL, Monaco S, Di Vito E, Mueller F, Marzano LA, Troncone G, Fenzi G, Rossi G, Vitale M 2005 Fibronectin-induced proliferation in thyroid cells is mediated by αvβ3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals. J Clin Endocrinol Metab 90:2865-2873
88. Eggo MC, Quiney VM, Campbell S 2003 Local factors regulating growth and function of human thyroid cells in vitro and in vivo. Mol Cell Endocrinol 213:47-58
89. Wang S, Wuu J, Savas L, Patwardhan N, Khan A 1998 The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Hum Pathol 29:1304-1309
90. Khoo ML, Ezzat S, Freeman JL, Asa SL 2002 Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab 87:1810-1813
91. Coppee F, Depoortere F, Bartek J, Ledent C, Parmentier M, Dumont JE 1998 Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Oncogene 17:631-641
92. Van Keymeulen A, Dumont JE, Roger PP 2000 TSH induces insulin receptors that mediate insulin co-stimulation of growth in normal human thyroid cells. Biochem Biophys Res Commun 279:202-207
93. Kimura T, Dumont JE, Fusco A, Golstein J 1999 Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: comparison with FRTL-5 cells. Eur J Endocrinol 140:94-103
94. Coulonval K, Bockstaele L, Paternot S, Roger PP 2003 Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis. J Biol Chem 278:52052-52060